1995). FIGURE 3. Schematic overview of pathways activated downstream of receptor tyrosine kinase (RTK) signaling. RTK receptors mediate outside signals to the interior of the cell through the cell ...
For example, BRAF V600E is often targeted by BRAFi such as vemurafenib, MEK by MEKi such as tramelinib, and HER2 by trastuzumab, Upon kinase inhibitor treatment, receptor tyrosine kinase (RTK) ...
1 2 Along with the progress of drug development, chemotherapy, targeted agents (ie, anti-epidermal growth factor receptor (EGFR ... Most of these alterations were involved in RTK-RAS and PI3K pathway, ...
Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2–Amplified Metastatic Colorectal Cancer: ...
Genetic mechanisms of resistance to kinase inhibitors include mutations in the target receptor and mutations or gene amplification of compensatory receptors or other signaling effectors.
Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study ...
Over the last years, many biological markers emerged that act as an adjunct for the detection of early bladder cancer recurrence. Some of these markers had a proven better sensitivity and ...
Based on the perceived low efficacy of current therapies targeted to FGFR2 in gastric cancer (GC), the authors investigate an approach which combines SHP2 inhibition with existing FGFR2 inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback